Pharmacology%20Study%20Guide%20-%20Infectious%20final.docx
Pharmacology Study Guide
Antibiotics Intro Classification of Antibiotics
- Antibiotics can be classified in 3 different ways
- Via their class and the spectrum of microorganisms they kill
- Ex: If antibacterial, can be gram (-) or (+)
- Broad spectrum vs Narrow spectrum
- Broad – kills many different types of bacteria
- Narrow – more selective targeting
- Via the biochemical pathway they interfere with
- Antibiotics target different parts of bacteria
- Cell wall inhibitors (ex: Penicllins)
- DNA synthesis inhibitors
- Via the chemical structure of its pharmacophore
- Do they have a beta lactam ring?
- Bactericidal Vs. Bacteriostatic
- Bactericidal
- Bactericidal antibiotics either kill or lyse cells
- If antibiotic targets cell wall, most likely bactericidal
- What happens?
- Antibiotics target different steps in the biochemical pathway of cell wall assembly
- Leads to a compromised cell wall with missing components
- Further divisions have weaker cell walls
- Integrity of cell wall fails
- Cells lyse and kill bacteria
- Concentration-dependent kill vs Time-dependent kill
- Concentration-dependent kill
- Increase in concentration kills more bacteria
- Even bacteriostatic drugs can be considered bactericidal at very high concentrations
- Ex: aminoglycosides, quinolones
- Time-dependent kill
- Based on threshold (MBC = minimum bactericidal concentration)
- As long as plasma concentration is above a certain threshold, the antibiotic will keep killing bacteria
If it dips below threshold, bactericidal effects will be gone
- Ex: Beta lactams, vancomycin
- Bacteriostatic
- Bacteriostatic antibiotics stop growth/interfere with growth of bacteria
- May be reversible
- Targets nucleic acid and protein synthesis
- Need normal immune function in patients (can’t be immunocompromised)
- Ex: Macrolides, tetracyclines
- When would you choose bactericidal over bacteriostatic?
- When the patient has a serious disease, such as meningitis
- Use a bactericidal to obtain a quicker effect (bacteriostatic takes longer to act)
- When the patient is immunocompromised (ex: older patients)
- Can’t give bacteriostatic because it would suppress their immunity, making them more prone to infections
- Bactrim (Sulfamethoxazole/Trimethoprim)
- Both components are bacteriostatic, but because it’s a combination, it’s
bactericidal
- Broad Spectrum vs Narrow spectrum
- Broad Spectrum
- Used when you don’t know the cause of infection
- Treats many different types of infection (wide range)
- Works by targeting structures or processes seen in many different bacteria
- Can cause Superinfection
- GI flora susceptible to broad spectrum antibiotics
- Leads to unwanted bacteria growing
- Stop giving once infectious agent is identified (switch to narrow spectrum)
- Narrow Spectrum
- Effective when infectious agent is known
- Targets specific molecule involved in bacterial metabolism
- Superinfection less likely
- Post-antibiotic effect
- PAE = T – C
- T: how long the bacterial will take to grow 10-fold in the presence of drug
- C: the time it will take to grow 10-fold if you weren’t taking the drug Antimicrobial Therapies
- Empirical: given before the pathogen responsible or the susceptibility to a particular antimicrobial agent is known
- Definitive: the pathogenic organism responsible for illness is identified
- Combination Antimicrobial Therapy
- Purpose:
- Provide broad-spectrum empiric therapy in seriously ill patients
- Treat polymicrobial infections
- Decrease emergence of resistant strains
- Decrease dose-related toxicity
- More enhanced inhibition/killing
HIV
3 genes/proteins to remember
- gag (Group-specific antigen)
- Makes matric and core proteins
- pol (Polymerase)
- Makes reverse transcriptase, protease, integrase
- env (Envelope)
- Makes envelop proteins, glycoproteins
- Gp120 (docking)
- Gp42 (membrane)
NRTIs (nucleoside reverse transcriptase inhibitors)
- NRTIs are all nucleoside analogs
- Thymine
- Stavudine, Zidovudine
- Adenine
- Didanosine, Tenofovir
- Cytosine
- Emtricitabine, Lamivudine
- Guanine
- Abacavir
- Aba, Ava, AVOcado makes GUAC (GUAnine)
- MoA: blocks replication in 2 manners
- Competitively inhibiting incorporation of native nucleotides
- Terminating elongation due to lack of 3’-hydroxy group
- Pillar of HIV therapy – most used drugs
- Can be given with other drugs, also with other NRTIs
- Don’t give 2 of the same nucleoside analogs!!! (ex: don’t give emtricitabine and lamivudine together)
- Abacavir
- Guanosine analog
- Most potent
- Alcohol increases serum levels
- Undergoes hepatic metabolism (detoxification reaction)
HLA b5701 test
- If patient tests positive, DO NOT give abacavir
- Increased risk of myocardial infarction
- Emtricitabine
- Cytosine analog
- Active against HIV and HBV
- Don’t use with lamivudine (same nucleoside analog)
- Contraindicated in young children and pregnant women (because propylene glycol in formulation)
- CNS depression, hemolysis, lactic acidosis
- Lamivudine
- Cytosine analog
- Recommended in pregnant women
- Tenofovir
- Acyclic nucleotide (adenosine)
- Only 2 steps of phosphorylation needed because already has one phosphate
PRODRUG
- Has ester groups that will get hydrolyzed
- Can cause loss of renal function and Fonconi’s syndrome
- Zidovudine
- Deoxythymidine analog
- Can give to pregnant women
- Can cause myelosuppression
- Lipoatrophy is another problem
- Abacavir doesn’t have these liver issues NNRTIs (Non-nucleoside reverse transcriptase inhibitors)
Allosteric inhibitors
- Non-competitive inhibitors
- Even 1 mutation can make them inactive – never use as a single agent, always given in combination
- Susceptible resistance by single mutation
- Only active against HIV-1
- Does not need to be phosphorylated
- Does not target host DNA polymerase
- MoA: binds directly to reverse transcriptase enzyme
- High hepatic metabolism ( CYP3A4) thus considerable D-D interaction
- Efavirenz
- Give on empty stomach (FYI: Conry asked questions on which one’s you take with meals or on empty stomach, so should know these)
- Metabolized by CYP2B6, CYP3A4
- CNS psychiatric effects
- SJS
- Avoid in pregnant women
- Increases serum cholesterol and liver enzymes
- Etravirine
- Better resistance profile
- Take with meals
- Nevirapine
- Rash and hepatotoxicity
- Causes opioid withdrawal
- For pregnant
- Rilpivirine
- Only for treatment naïve patients -1st time
- Take with meals
- Do not take with antacids or H2 antagonists
- Has to be separated with antacids by 2-6 hours
- Causes fat redistribution and QT prolongation Protease inhibitors
- All end in -navir
- Protease cleaves between phenylalanine and proline
- Blocking this affects viral protein maturation
- Causes dyslipidemia, cardiac issues
- Atazanavir
- Needs acidic medium for absorption
- Take with meals
- Good for pregnant women
- No dyslipidemia (unlike the other one’s)
- Darunavir
Give with ritonavir
- Take with meals
- Hepatotoxicity and hypersensitivity
- All protein inhibitors with sulfa has hypersensitivity potential
- Fosamprenavir
- Prodrug of amprenavir with phosphate group
- Hypersensitivity (b/c sulfa)
- Oral solution has propylene glycol so contraindicated in young children and pregnant women
- Ritonavir
- Good for pregnant women
- Major use is to reduce pill burden of other drugs
- Can increase theophylline and digoxin levels
- Metabolized Cyp3a4 2d6, low dose
- Do not give with saquinavir due to QT prolongation Entry Inhibitors (Maraviroc)
- Glycoprotein is attached to CD4 receptor
- That leads to the 2nd leg being attached to the CCR5 core receptor
- Maraviroc binds to CCR5 (CCR5 receptor antagonist), preventing gp120 binding, fusion, and entry
- This drug only works on patients who have CCR5 (some patients have CXCR4)
- Resistance
- V3 loop of gp120 protein
- Virus changing to CXCR4 tropism Fusion inhibitors (enfuvirtide)
- enFU (FUsion)
- Blocks interaction between N36 and C34 sequences of gp41 glycoprotein by binding to N36 coil
- Prevents formation of a six-helix bundle critical for membrane fusion and viral entry
- Inhibits infection of CD4+ cells
- Still works in viruses with RT mutations
- Subcutaneous injection
- Mutations in gp41 causes resistance Integrase strand transfer inhibitors (INSTI)
- Both end with -gravir
- dsRNA genome (this happens by integrase)
- INSTIs block from happening
- Binds to HIV integrase, preventing DNA strand transfer
- Active for HIV-1 and 2
- Dolutegravir
- Caution with antacids, laxatives, iron and calcium supplements
- UGT1A1 (glucuronide formation) metabolism
- Active against viruses resistant to other INSTIs
- Raltegravir
- UGT1A1
- Single point mutation resistance
- sjs
- Don’t give with antacids Post-attachment inhibitors (ibalizumab)
- Only give in patients that were treated with other drugs already
- Multi-drug resistant HIV-1
- Binds to CD4, similar mechanism as maraviroc
- Prevents binding of gp120 to CD4 by binding to CD4
- AE: immune reconstitution inflammatory syndrome
- Excessive/exaggerated immune response to other infection patients get
Fostemavir = attachment inhibitor
Cobicistat
- Inhibitor of CYP3A
- Given in combination with HIV drugs so their concentration increases
- Increased pill burden
Bictegravir
-IRIS, hepatomegaly with steatosis, lactic acidosis, nephrotoxicity, UGT1A1, CYP3A4
Antiviral
Treatment of Herpes Simplex Virus and Varicella Zoster Virus Acyclovir
- Acyclic guanine nucleoside analog
- Lacks 3’-hydroxyl
- 5’ and 3’ are ends of DNA (5’ is start, 3’ is end)
- Normally nucleosides have 2 hydroxyl groups
- Mostly good for HSV1 and HSV2
- Mechanism of action
- Acyclovir gets phosphorylated by thymidine kinase
- Once phosphate group is added, body’s enzymes adds 2 more phosphates (becomes acyclovir triphosphate)
- Once converted to triphosphate, goes into cell nucleus, and participates as a nucleotide in nucleic acid synthase
- Combine its phosphate with hydroxyl group of earlier nucleotide
- Due to the lack of 2nd hydroxyl group in acyclovir structure, DNA synthesis stops
- Like a chain of people holding hands, but last person missing an arm, so hand holding chain stops there (these are the types of analogies dukhande makes)
- Called chain termination
- Inhibits herpes DNA polymerase by binding to the pyrophosphate site
- Pyrophosphate binds to herpes DNA polymerase, and is normally removed
- When acyclovir binds, it doesn’t get removed, so acts as an inhibitor of herpes DNA polymerase
- Competitive inhibitor at pyrophosphate site
- So 2 actions: chain termination, and inhibiting DNA polymerase
- Resistance:
- Mutation in thymidine kinase
- Mutation in DNA polymerase
- Can use foscarnet, cidofovir, or trifluridine in these cases
- Foscarnet looks like an organic phosphate
- Cidofovir already has the first phosphate (so doesn’t need thymidine kinase)
- Trifluridine is a pyrimidine, so inhibits a different enzyme
- Oral: genital herpes, chicken pox, shingles
- IV: serious herpes, immunocompromised patients
- IV form nephrotoxic and or neurotoxic
- Topical: cold sores
- Prophylaxis: organ transplant patients to prevent symptoms Valacyclovir
Prodrug
- 1-valyl ester of acyclovir
- Only oral route Famciclovir and Penciclovir
- Famciclovir is a prodrug of penciclovir
- Acyclic guanine nucleoside analog
- 2 hydroxyl groups
- 1 MoA: inhibition of viral DNA polymerase
- Cannot terminate chain because 2 hydroxyls
- Not as good as acyclovir or valacyclovir
- Only advantage is longer half life
- Good for HSV1, HSV2, VZV
Docosanol
- Prevents viral entry by inhibiting fusion of viral envelope to host plasma membrane
- Useful in early stage, because once the virus is already inside, drug is useless
- Used for cold sores (Abreva)
- Used for recurrent herpes Trifluridine
- Fluorinated pyrimidine nucleoside
- Kills DNA synthesis, but also our DNA synthesis
- Phosphorylated by host enzymes to triphosphate (does not need thymidine kinase) and incorporated by viral DNA polymerase
- Monophosphate form blocks thymidine synthase
- AE: hypersensitivity Idoxuridine
- Iodinated thymidine analog
- Too toxic for systemic, so given topically Foscarnet
- Mimics inorganic-pyrophosphate
- Blocks pyrophosphate binding site on viral DNA polymerase
- Given in acyclovir resistance
- Deposited in bones because it’s a phosphate
- IV only
- Resistance: point mutations in DNA polymerase
- SE: nephrotoxicity (same like acyclovir) CMV Infection
Ganciclovir
- Acyclic guanosine analog
- Triphosphorylated by viral UL97 and host kinases
- 2 hydroxyl groups so only 1 mechanism of action (inhibition of DNA polymerase)
- Resistance: mutations in UL97 kinase; UL54 mutation in DNA polymerase
- AE: myelosuppression Valgancyclovir
- L-valyl ester prodrug of ganciclovir
- Given orally
- Take with food Cidofovir
- Cytosine analog
- Both start with C
- Already has 1 phosphate so doesn’t need thymidine kinase
- 2 hydroxyl groups so no chain termination
- Only MoA: DNA polymerase inhibition
- AE: nephrotoxicity (should know which ones are nephrotoxic Influenza
Pandemic – outbreak of disease that has spread throughout a large region or globally Epidemic – a disease that appears as new cases at a rate that substantially exceeds what is expected
- Ex: when flu comes and it’s more resistant Endemic – restricted to particular region
- Ex: Malaria restricted to topical areas Antigenic Drift
- Small changes in genes of influenza virus
- Produces viruses that are closely related to each other
- Small changes accumulate over time and can become drastically different from original gene
- Main reason why people can get flu more than one time, and why flu vaccination always updating
Antigenic Shift
- Abrupt major change in virus, resulting in new proteins that infect humans
- Recombination leads to totally different flu HA and NA
- HA (Hemagglutinin)
- Needed for viral attachment and membrane fusion
- NA (Neuraminidase)
- Helps virus to escape
- Cleaves sialic acid from cell surface
- When we get flu, body develops huge amount of mucous
- Mucous is very sticky due to sialic acid
- Virus breaks sialic acid so it can infect other cells, otherwise it gets trapped
Oseltamivir
- Analog of sialic acid
- Instead of NA cleaving sialic acid, it will cleave oseltamivir instead
- Virus can’t escape and gets trapped
- Resistance: mutation in HA and NA
- Active for Influenza A and B
- Other drug class (Amantadine one) only good for influenza A
- Active against amantadine-resistant influenza
- Early administration is crucial (Etzel emphasizes this more later)
- Need to give within 48 hours
- Neuropsychiatric events in Japan Zanamivir
- Can be given via inhalation
- Mostly for adults, do not give if <8 y.o Peramivir
- 18 years or older
- Same MoA
- Neuropsychiatric events Amantadine and Rimantadine
- Prevents the drug from growing inside the cell
- Binds to the M2 channel (proton channel)
- Virus goes in the cell through endosomes and undergoes uncoating
- After uncoating, it goes in the nucleus and makes more copies
- For uncoating, pH has to be acidic
- Acidic pH maintained by using proton pump
- Amantadine binds to the proton pump, prevent its actions, preventing endosomes from being acidic, and preventing uncoating
Do not give in pregnant women
- Influenza A only
- CNS issues
Antifungals
- 2 drugs that don’t act on the cell wall: Flucytosine and tavaborole
- Squalene squalene epoxide lanosterol
- Terbinafine blocks squalene into squalene epoxide
- Lanosterol turns into ergosterol, and is blocked by azoles
- Amphotericn B, nystatin act on membrane and form pores through the fungal membrane
- Beta glucan synthase blocked by enchinocandins Amphotericin B
- Given IV
- Has affinity for ergosterol and cholesterol
- Binding activity: Cholesterol < Liposomal vehicle < Ergosterol
- Binds to ergosterol and produces disorganization of membrane by formation of pores
- Depolarizes cell membrane and increases permeability
- Resistance: ergosterol medication
- AE: Nephrotoxicity
Flucytosine
- Used in combination with amphotericin B or fluconazole
- Taken up by fungal cells via cytosine permease
- Converted into 5-FU, and then FdUMP and FUTP
- FdUMP inhibits DNA synthesis (both have D)
- FUTP inhibits RNA synthesis
- AE: bone marrow toxicity Azoles
- Decrease ergosterol biosynthesis by inhibiting CYP450 enzyme: 14-a-sterol demethylase
- Triazoles more selective
- Resistance: mutation in ERG11, increased azole efflux, mutation in ERG3 Ketoconazole
- Only used topically Itraconazole
- Oral, IV
- AE: Hepatotoxicity Fluconazole
- Can be used for streptococcal meningitis
- Start with amphotericin B, then give fluconazole Voriconazole and Posaconazole
- Good for aspergillosis and molds
- Visual disturbance
- Posaconazole covers mucormycosis Isavuconazole
- Invasive aspergillosis
- Invasive mucormycosis
Echinocandins (Caspofungin, Micafungin, Anidulafungin)
- Non-competitive inhibitors of Beta 1,3-glucan synthase
- Causes disruption of fungal cell wall and death
- Therapy against invasive candidiasis and invasive aspergillosis
- Resistance: mutation in Beta 1,3-glucan synthase
- Given IV Griseofulvin
- Fungistatic drug
- Inhibits fungal mitosis by inhibiting spindle formation Terbinafine
- Fungicidal drug
- Inhibits fungal squalene epoxidase
Antiprotozoal
What happens in Malaria (maybe just watch a video tbh)
- Infected female mosquito bite (something called a sporozoite is initially injected, and nothing can kill this)
- Entry into hepatocytes via cell surface receptors
- Exoerythrocytic stage (1 week) asexual reproduction liver schiznts (AKA hyponozoites)
- Latent phase
- Hepatocyte rupture, merozoites released in blood
- Asexual erythrocytic stage erythrocytic schizonts replicated release and infect other erythrocytes
- Cyclic fever pattern
- Erythrocytic form gametocytes -> ingested by mosquito sexual reproduction in mosquito repeat
Categories of Anti-malarials
- Erythrocytic schizonts
- Erythrocytic and hepatocyte schizonts
- Primary and latent liver stage and gametocytes
- Only Primaquine active in this stage
- No agent targets all stages, so combination therapy needed Artemisinins
- Sesquiterpene lactone endoperoxide
- Iron from heme reacts with peroxide moiety
- Generates ROS and alters cellular redox cycle
- Blocks Pf proteins that have role in calcium transport
- Blood schizonticide
- AE: neutropenia, anemia, hemolysis
- Can be given in late pregnancy (2nd and 3rd trimester, NOT FIRST) Chloroquine
- Passes membrane, accumulates in lysosomes
- Binds heme, changes osmotic properties of lysosomes and prevents heme detoxification
- Causes iron toxicity, and parasite gets killed
- Blood schizonticide, gametocide
- AE: patients with G6PDH deficiency – hemolysis
- Do not take with antacids
- Safe in pregnant women Amodiaquine
- MoA similar to chloroquine Piperaquine
- Long half life Quinine and Quinidine
- Blood schizonticide against all 4
- Gametocidal against vivax and ovale but not falciparum
- Not active against hepatic
- Resistance: PfMDR1
- More toxic and less effective than chloroquine
- AE: cinchonism, babeosis, blackwater fever
- Don’t give with mefloquine Mefloquine
- Prophylaxis and combination with artesunate
- MoA similar to chloroquine
- Safe in pregnancy
- Resistance: PfMDR1
- Recommended in chloroquine-resistant regions
- Black-box warning for neurologic and psychiatric toxicities
- Don’t give in pregnancy
- Don’t co-administer with quinines Primaquine
- Used to eradicate dormant forms of vivax and ovale
- Active against hepatic forms, gametocidal
- Weak activity against blood schizonts
- Causes oxidative stress, which kills parasites
- G6PD deficiency causes hemolysis (same with chloroquine) Atovaquone
- Disrupts mitochondrial ETC of parasite
- Active against tissue and blood schizonts Halofantrine
- MoA unknown, related to heme solubilization disruption
Cardiac conduction problems
Lumefantrine
- No cardiac problems like halofantrine of quinidine Amebiasis
- Extraluminal (liver parasite)
- Luminal (GI parasite) Metronidazole and Tinidazole
- Nitroimidazole
- Drug of choice for extraluminal amebiasis
- Inhibits nucleic acid synthesis
- Disrupts DNA and causes strand breakage
- Action dependent on reduction of nitro group
- AE: pancreatitis, severe CNS toxicity Iodoquinol
- Luminal amebicide
- Not active against trophozoites or extraintestinal Paromomycin Sulfate
- Aminoglycoside antibiotic
- Luminal amebicide
- Antiamebic luminal agent of choice in USA